長城動漫(000835.SZ):大洲娛樂合計持股升至14.12%
格隆匯5月5日丨長城動漫(000835.SZ)公佈,2020年3月12日10時至3月13日10時止,廣東省深圳市福田區人民法院在淘寶網司法拍賣網絡平台對長城影視文化企業集團有限公司持有的公司無限售流通股1000萬股股份進行公開拍賣,起拍價為2916.2880萬元。大洲娛樂股份有限公司(“大洲娛樂”)以3126.288萬元競得上述股權,佔公司總股本的2.54% 。2020年4月2日,已辦理股份過户手續。
大洲娛樂為公司第二大股東,此次競買前持有公司股份3784.4萬股,佔公司總股本的11.58%;此次權益變動後,大洲娛樂合計持有公司股份達到4614.4萬股,佔公司總股本的14.12%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.